A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2006
10/19/2006	US20060233769 Established cell line of microglia
10/19/2006	US20060233768 Elective collection and banking of autologous peripheral blood stem cells
10/19/2006	US20060233761 Alkyl-glycoside enhanced vaccination
10/19/2006	US20060233760 Splicing variant of TGF-beta2 and uses thereof
10/19/2006	US20060233759 Adenoviral vectors having a protein IX deletion
10/19/2006	US20060233758 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
10/19/2006	US20060233757 Vectors with viral insulators
10/19/2006	US20060233756 Recombinant adenoviral vectors and applications thereof
10/19/2006	US20060233755 A virus envelope vector encapsulating a hepatocyte growth factor (HGF) gene or its plasmid as an active ingredient; gene therapy for the prevention and treatment of deafness
10/19/2006	US20060233754 A kit containing a compound promoting delivery of exogenous genes to cells, e.g., 1-(5-chloro-2-hydroxyphenyl)-3-(3-pyridinyl)-1,3-propanedione; 1-Tetradecylarsonic acid; N1-(2-fluoro-9-acridinyl)-N3N3-dimethyl-1,3-propanediamine; and N4(bis(2-chloroethy)amino)benzylidene)1,3-thiazol-2-amine
10/19/2006	US20060233753 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs
10/19/2006	US20060233745 Enclosures housing cell-coated supports for treating tumors
10/19/2006	US20060233712 Magnetic nanoparticles
10/19/2006	CA2605253A1 Selective modulation of tumour necrosis factor receptors in therapy
10/19/2006	CA2604883A1 Adam10 in cancer diagnosis, detection and treatment
10/19/2006	CA2604441A1 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
10/19/2006	CA2604288A1 Use of a galectin-1-targeted rnai-based approach for the treatment of cancer
10/19/2006	CA2604135A1 Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use
10/19/2006	CA2603842A1 Rnai therapeutic for respiratory virus infection
10/18/2006	EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/18/2006	EP1712243A1 Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
10/18/2006	EP1711629A1 Method for detecting the risk of cardiovascular diseases such as acute myocardial infarction and coronary heart disease by analysing defensin
10/18/2006	EP1711518A2 Chimpanzee adenovirus vaccine carriers
10/18/2006	EP1711510A2 Rnai therapeutics for treatment of eye neovascularization diseases
10/18/2006	EP1711509A2 Inhibition of bright function as a treatment for excessive immunoglobulin production
10/18/2006	EP1711210A2 Combined use of prame inhibitors and hdac inhibitors
10/18/2006	EP1711209A1 Methods of treating mesothelioma using an antisense oligonucleotide to thymidylate synthase
10/18/2006	EP1711206A2 Compositions and methods of use of w-peptides
10/18/2006	EP1711187A2 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
10/18/2006	EP1711172A2 Compositions and methods for combined therapy of disease
10/18/2006	EP1711163A2 Dispersions prepared by use of self-stabilizing agents
10/18/2006	EP1680085A4 A novel cationic lipopolymer as a biocompatible gene delivery agent
10/18/2006	EP1404872B1 Method of selecting a dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
10/18/2006	EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
10/18/2006	EP1332206B1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
10/18/2006	EP1246649B1 Intravascular delivery of nucleic acid
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	EP1194554B1 Delivery of trefoil peptides
10/18/2006	EP1183383B1 Siv-based packaging-deficient vectors
10/18/2006	EP1180039B1 Composition for the treatment of a neurological disorder
10/18/2006	EP1171601B1 Nucleic acids encoding a mutt domain-containing polypeptide
10/18/2006	EP1165778B1 Uses of casb618 polynucleotides and polypeptides
10/18/2006	EP1019500B1 Ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
10/18/2006	EP1004667B1 Cell cycle-regulating proteins
10/18/2006	EP1003533B1 Use of herpes vectors for tumor therapy
10/18/2006	EP0969862B1 Synthetic hiv gag genes
10/18/2006	EP0939828B1 Herpesvirus saimiri as viral vector
10/18/2006	CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006	CN1849396A Improved inhibitor nucleic acids
10/18/2006	CN1849395A HLA-a24 binding cancer antigen peptide derived from ribin
10/18/2006	CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1
10/18/2006	CN1849069A Modified oligonucleotides for telomerase inhibition
10/18/2006	CN1847397A EHEC 0157 shiga-like toxin IIA resisting subunit monoclonal antibody 5F3 light and heavy chain variable region gene and its application
10/18/2006	CN1846791A Medicine composition for preventing and treating mammitis
10/18/2006	CN1846786A Vaccins vivants recombines et adjuves
10/18/2006	CN1280414C Human antibody heavy chain and light chain variable region gene against SARS-Cov S antigen and polypeptide and use thereof
10/18/2006	CN1279982C Ultrasonic microbubble contrast medium containing gene
10/18/2006	CN1279979C Nucleic vaccine for tubercle bacillus
10/18/2006	CN1279971C Novel method for down-regulation of amyloid
10/17/2006	US7122654 Hybrid; adjust vascular system permeability
10/17/2006	US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene
10/17/2006	US7122649 Derivatized oligonucleotides having improved uptake and other properties
10/17/2006	US7122639 Chemokine alpha-2 antibodies
10/17/2006	US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/17/2006	US7122621 Contains domains capable of forming amphipathic alpha helix, for cell lysis; site-directed mutagenesis; for treatment of leukemia or stomach carcinoma
10/17/2006	US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
10/17/2006	US7122527 Use of antisense oligonucleotides to inhibit the expression of human Akt-1
10/17/2006	US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006	US7122361 Compositions employing a novel human kinase
10/17/2006	US7122348 Adeno-associated viral deletion rep protein comprising functional nuclear localization sequence for use delivery of gene products to preferential intracellular locations
10/17/2006	US7122343 Providing a transformed host cell comprising an isolated nucleic acid molecule, expressing the nucleic acid molecule in the transformed host cell as recombinant DNA repair polypeptide, wherein the amount of the recombinant polypeptide produced by the transformed cell is different
10/17/2006	US7122311 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
10/17/2006	US7122307 High throughput biological heart rate monitor that is molecularly determined
10/17/2006	US7122192 Porcine circoviruses, vaccines and diagnostic reagents
10/17/2006	US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody
10/17/2006	US7122181 Gene therapy; eye diseases
10/17/2006	US7122180 DNA vectors containing mutated HIV proviruses
10/12/2006	WO2006107990A2 Improving protein n-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other n-gylosylation-increasing methods, and engineered hosts expressing products with increased n-glycosylation
10/12/2006	WO2006107949A2 Methods of protection from oxidative stress
10/12/2006	WO2006107751A2 Combined therapy utilizing reduction of dna methyltansferase expression and/or activity and interferon
10/12/2006	WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding
10/12/2006	WO2006106521A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
10/12/2006	WO2006106519A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
10/12/2006	WO2006105998A2 Treatment of cognitive and learning impairment
10/12/2006	WO2006091222A3 Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118
10/12/2006	WO2006087637A3 Anti her2/neu antibody
10/12/2006	WO2006062402A3 Heat shock proteins (hsp) and supraventricular arrhythmia
10/12/2006	WO2006039792A8 Method of treating autoimmune diseases
10/12/2006	WO2006034354A3 Methods of diagnosing and treating vhl associated tumors and sporadic renal cell carcinoma, other vhl sporadic counterpart tumors and non-tumor lesions which co-express epo and the epo receptor
10/12/2006	WO2005086695A3 Intracellular interleukin-1 receptor antagonist and uses thereof
10/12/2006	WO2005032459A3 Erythrosin-based antimicrobial photodynamic therapy compound and its use
10/12/2006	US20060230467 Plant deoxyribonucleoside kinase enzymes and their use
10/12/2006	US20060229273 High affinity oligonucleotide ligands to growth factors
10/12/2006	US20060229272 or biological fragments in a colon test sample and comparing to that from a normal colon sample, wherein an increased expression level is indicative of gastrointestinal disorders or a predisposition to gastrointestinal disorders
10/12/2006	US20060229271 Methods for treating infectious disease exacerbated asthma
10/12/2006	US20060229270 Methods of treating proteinuria by reducing double-stranded DNA antibodies
10/12/2006	US20060229269 administering to a subject having cerebral vasospasm an effective amount for treating cerebral vasospasm of a R-type voltage-dependent calcium channel inhibitor SNX-482 ( a polypeptide from spider; toxin from the venom of the tarantula Hysterocrates gigas)
10/12/2006	US20060229268 Small interference RNA (siRNA) molecules for modulating superoxide dismutase (SOD)
10/12/2006	US20060229267 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a c-Ha-ras gene and the second hybridizing to a different type of oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers
10/12/2006	US20060229266 Silencing of tgf-beta receptor type II expression by sirna

1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 870